PL1959933T3 - Sposób wytwarzania liofilizowanej soli sodowej piperacyliny w kombinacji z solą sodową tazobaktamu o ulepszonej trwałości po odtworzeniu - Google Patents

Sposób wytwarzania liofilizowanej soli sodowej piperacyliny w kombinacji z solą sodową tazobaktamu o ulepszonej trwałości po odtworzeniu

Info

Publication number
PL1959933T3
PL1959933T3 PL06830298T PL06830298T PL1959933T3 PL 1959933 T3 PL1959933 T3 PL 1959933T3 PL 06830298 T PL06830298 T PL 06830298T PL 06830298 T PL06830298 T PL 06830298T PL 1959933 T3 PL1959933 T3 PL 1959933T3
Authority
PL
Poland
Prior art keywords
sodium
combination
reconstitution
preparation
improved stability
Prior art date
Application number
PL06830298T
Other languages
English (en)
Inventor
Joan Cabre
Josep Salvador
Pere Lloveras
Irina Kosilek
Norbert Atzl
Jose Diago
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL1959933T3 publication Critical patent/PL1959933T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06830298T 2005-12-05 2006-12-01 Sposób wytwarzania liofilizowanej soli sodowej piperacyliny w kombinacji z solą sodową tazobaktamu o ulepszonej trwałości po odtworzeniu PL1959933T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74240805P 2005-12-05 2005-12-05
PCT/EP2006/069232 WO2007065862A1 (en) 2005-12-05 2006-12-01 Process for the perparation of lyophilized piperacilline sodium with improved stability after reconstitution
EP06830298A EP1959933B1 (en) 2005-12-05 2006-12-01 Process for the preparation of lyophilized piperacillin sodium in combination with tazobactam sodium, with improved stability after reconstitution

Publications (1)

Publication Number Publication Date
PL1959933T3 true PL1959933T3 (pl) 2011-04-29

Family

ID=37806963

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06830298T PL1959933T3 (pl) 2005-12-05 2006-12-01 Sposób wytwarzania liofilizowanej soli sodowej piperacyliny w kombinacji z solą sodową tazobaktamu o ulepszonej trwałości po odtworzeniu

Country Status (12)

Country Link
US (1) US20090186865A1 (pl)
EP (1) EP1959933B1 (pl)
JP (1) JP5004964B2 (pl)
CN (1) CN101299995B (pl)
AT (1) ATE485043T1 (pl)
CA (1) CA2629599C (pl)
DE (1) DE602006017732D1 (pl)
DK (1) DK1959933T3 (pl)
ES (1) ES2354910T3 (pl)
PL (1) PL1959933T3 (pl)
SI (1) SI1959933T1 (pl)
WO (1) WO2007065862A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101269072B (zh) * 2008-05-09 2010-06-02 郑飞雄 含量稳定的含β-内酰胺酶抑制剂和哌拉西林钠的药物组合物及其制备方法
CN101632677B (zh) * 2009-08-26 2013-11-20 海南永田药物研究院有限公司 一种头孢哌酮钠他唑巴坦钠药物组合物混悬粉针剂及其新应用
JP5852316B2 (ja) * 2010-03-30 2016-02-03 富山化学工業株式会社 ピペラシリン含有懸濁液の製造法
CN102382123A (zh) * 2011-03-10 2012-03-21 海南美好西林生物制药有限公司 一种他唑巴坦钠的制备方法
CN102228460A (zh) * 2011-04-12 2011-11-02 宁辉 一种抗菌药物组合物及其制备方法
WO2013014544A1 (en) * 2011-07-25 2013-01-31 Vardhman Chemtech Limited Method for preparation of composition of piperacillin sodium and tazobactam sodium
EP2862569A1 (en) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
DE102012021655B4 (de) 2012-11-03 2023-03-30 Hof Sonderanlagenbau Gmbh Verfahren zur Gefriertrocknung eines mit einem Lösungsmittel versehenen, feuchten Produktes
CN103054818B (zh) * 2013-01-28 2014-03-05 苏州二叶制药有限公司 一种优质高效的冷冻干燥技术
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102226197B1 (ko) * 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
CN103239454B (zh) * 2013-05-06 2014-11-05 齐鲁天和惠世制药有限公司 一种注射用哌拉西林钠他唑巴坦钠冻干制剂的生产方法
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103550216B (zh) * 2013-10-30 2015-03-11 济南康和医药科技有限公司 一种哌拉西林钠他唑巴坦钠药物组合物及其制备方法
CN104083372A (zh) * 2014-07-13 2014-10-08 江苏海宏制药有限公司 降低注射用哌拉西林钠他唑巴坦钠有关物质的方法
CN106714799A (zh) * 2014-10-08 2017-05-24 泽井制药株式会社 冷冻干燥制剂的制造方法
CN105640959B (zh) * 2016-01-23 2017-03-15 阎虎林 哌拉西林钠和他唑巴坦钠药物组合物
DE102017217415B4 (de) * 2017-09-29 2022-11-10 OPTIMA pharma GmbH Verfahren und Vorrichtung zur Gefriertrocknung
CN112076162A (zh) * 2020-08-07 2020-12-15 安徽康正康仁药业有限公司 一种注射用哌拉西林钠他唑巴坦钠丙磺舒钠三方冻干制剂
CN112409381B (zh) * 2020-12-03 2022-03-01 山东安信制药有限公司 一种哌拉西林钠他唑巴坦钠共无定形物及其制备方法
CN112618486B (zh) * 2020-12-24 2023-07-18 浙江昂利康制药股份有限公司 一种注射用混悬油剂及其制备方法
CN113209030B (zh) * 2021-04-27 2023-04-25 海南通用康力制药有限公司 哌拉西林钠他唑巴坦钠无菌粉针剂的制备方法
CN113750057A (zh) * 2021-10-28 2021-12-07 江苏睿实生物科技有限公司 一种注射用哌拉西林钠他唑巴坦钠冻干剂的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230095B (it) * 1989-04-27 1991-10-05 Parenta Srl Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici.
US20040017918A1 (en) * 2002-07-24 2004-01-29 Christophe Nicolas Process for point-to-point secured transmission of data and electronic module for implementing the process
US6900184B2 (en) * 2003-04-14 2005-05-31 Wyeth Holdings Corporation Compositions containing pipercillin and tazobactam useful for injection
CN1913890A (zh) * 2004-01-30 2007-02-14 惠氏公司 大体上不含半乳甘露聚糖且含有哌拉西林(piperacillin)和他唑巴坦(tazobactam)的组合物

Also Published As

Publication number Publication date
US20090186865A1 (en) 2009-07-23
EP1959933A1 (en) 2008-08-27
CA2629599A1 (en) 2007-06-14
DK1959933T3 (da) 2011-02-07
EP1959933B1 (en) 2010-10-20
CA2629599C (en) 2014-04-01
ES2354910T3 (es) 2011-03-21
CN101299995A (zh) 2008-11-05
DE602006017732D1 (de) 2010-12-02
SI1959933T1 (sl) 2011-02-28
JP2009518355A (ja) 2009-05-07
ATE485043T1 (de) 2010-11-15
WO2007065862A1 (en) 2007-06-14
CN101299995B (zh) 2013-04-24
JP5004964B2 (ja) 2012-08-22

Similar Documents

Publication Publication Date Title
PL1959933T3 (pl) Sposób wytwarzania liofilizowanej soli sodowej piperacyliny w kombinacji z solą sodową tazobaktamu o ulepszonej trwałości po odtworzeniu
UA103363C2 (ru) Способ ферментативного производства четырехатомных спиртов
WO2007041269A3 (en) Fermentive production of four carbon alcohols
GB2497218A (en) Method and system for pacing, ack'ing, timing, and handicapping (path) for simultaneous receipt of documents
TW200700092A (en) Tigecycline compositions and methods of preparation
CL2012001336A1 (es) Composicion farmaceutica solida de daptomicina preparada por liofilizacion de una solucion acuosa que comprende daptomicina y al menos un excipiente seleccionado de glicina y un azucar no reductor con un ph de 6,5-7,5; producto farmaceutico; metodo de fabricacion; uso para tratar infecciones bacterianas.
NZ616202A (en) Production of soluble protein solutions from soy (“s701”)
AR087531A2 (es) Una bebida que contiene goma gellan con alto contenido de acilo, estable ante el calcio para conseguir estabilidad coloidal mejorada
CL2008003238A1 (es) Uso de carbonato calcico natural tratado en superficie como relleno en productos de papel, producto de la reaccion de carbonato calcico natural con acido y dioxido de carbono; proceso de fabricacion de papel de seda; y papel de seda.
WO2006113897A3 (en) Products and methods for in vivo secretion of monatin
MY158663A (en) Fermentation broth formulations
GB2492267A (en) Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals and amino acids
MY170602A (en) Process for fractionation of biomass
PH12014501556A1 (en) Microorganism able to produce l-amino acid, and method for producing l-amino acid by using same
BRPI0919755B8 (pt) escherichia coli produtora de 2-desóxi-scilo-inosose (doi) e método de produção de doi
MX2010007404A (es) Procedimiento para la preparacion de asenapina y productos intermediarios utilizados en dicho procedimiento.
WO2011123154A3 (en) Metabolic evolution of escherchia coli strains that produce organic acids
PL1871669T3 (pl) Sposób wytwarzania ciekłych preparatów o zawartości ciał stałych
MX2009003553A (es) Uso de goma arabiga para mejorar el crecimiento y supervivencia de bifidobacteria.
NZ611788A (en) Astringency in soy protein solutions
BR112012015449A2 (pt) suspensão de monoidrato de calcipotriol, monoidrato de calcipotriol, processo para preparar nanocristais de monoidrato de calcipotriol, e, composição farmacêutica
HK1147751A1 (en) Carbamoylglycine derivatives
MX2011012487A (es) Proceso para preparar un producto a base de soya fermentada.
WO2008013807A3 (en) A novel lactic acid formulation of mk-0457 useful for the treatment of cancer
UA48068U (ru) Способ прививки бука лесного